Granulomatosis with Polyangiitis (GPA) is a rare autoimmune disease that causes inflammation of small- and medium-sized blood vessels, potentially affecting organs such as the lungs, kidneys, sinuses, and joints. Because of its complexity, patients and families often face many questions about symptoms, diagnosis, treatment, and long-term management.In this VF webinar, What You Need to Know about GPA Vasculitis, is presented by Dr. Audra Hornomanski,a rheumatologist and Clinical Assistant Professor in the Division of Immunology and Rheumatology at Stanford University. In this session, Dr. Hornomanski will provide a clear and comprehensive overview of GPA0:005:57 Understanding granulomatosis with polyangiitis7:20 What causes GPA?9:46 Signs and symptoms16:12 Other symptoms18:57 Diagnostic tests24:55 Treatment for severe disease33:12 Treatment for non-severe disease35:26 Other important information about the treatment plan37:33 Treatment: Sinus disease38:33 Disease monitoring39:36 Reproductive health40:48 Upcoming and ongoing research40:41 Is there information available about women in menopause taking transdermal HRT and the risk of blood clots? My understanding the risk is lower when using transdermal. Is that correct? I would love to have info to share with my doctors.46:49 Does a persistently elevated ANCA titer without classic findings of vasculitis have clinical significance?48:04 Why does extreme fatigue linger even after you're in long-term remission? More exercise makes it worse. What do you recommend?50:53   As the director of the Stanford Vasculitis clinic, do you participate in any educational sessions with your ENT providers to identify symptoms quickly and minimize the diagnosis time for GPA patients?52:04 Once you're ANCA positive, are you always ANCA positive even in remission? Can you be ANCA positive and NOT have GPA (or eGPA or MPA)? If so, what could cause this?53:51 Is long-term use (years) of methotrexate considered safe for GPA (sinus) to keep it in remission?54:55 What is the distinction between severe and non-severe GPA?56:12 My nephrologist says I can stop or do 6 months or once a year. My rheumatologist says I should keep doing it every 6 months. How often should a person do rituximab after remission? 58:04  Do you ever see a delay between symptoms in patients and elevation of labs reflecting inflammation, and what is the typical timeframe between onset of symptoms and reflecting of inflammation in labs?

Granulomatosis with Polyangiitis (GPA) is a rare autoimmune disease that causes inflammation of small- and medium-sized blood vessels, potentially affecting organs such as the lungs, kidneys, sinuses, and joints. Because of its complexity, patients and families often face many questions about symptoms, diagnosis, treatment, and long-term management.
In this VF webinar, What You Need to Know about GPA Vasculitis, is presented by Dr. Audra Hornomanski,a rheumatologist and Clinical Assistant Professor in the Division of Immunology and Rheumatology at Stanford University. In this session, Dr. Hornomanski will provide a clear and comprehensive overview of GPA

0:00
5:57 Understanding granulomatosis with polyangiitis
7:20 What causes GPA?
9:46 Signs and symptoms
16:12 Other symptoms
18:57 Diagnostic tests
24:55 Treatment for severe disease
33:12 Treatment for non-severe disease
35:26 Other important information about the treatment plan
37:33 Treatment: Sinus disease
38:33 Disease monitoring
39:36 Reproductive health
40:48 Upcoming and ongoing research
40:41 Is there information available about women in menopause taking transdermal HRT and the risk of blood clots? My understanding the risk is lower when using transdermal. Is that correct? I would love to have info to share with my doctors.
46:49 Does a persistently elevated ANCA titer without classic findings of vasculitis have clinical significance?
48:04 Why does extreme fatigue linger even after you're in long-term remission? More exercise makes it worse. What do you recommend?
50:53 As the director of the Stanford Vasculitis clinic, do you participate in any educational sessions with your ENT providers to identify symptoms quickly and minimize the diagnosis time for GPA patients?
52:04 Once you're ANCA positive, are you always ANCA positive even in remission? Can you be ANCA positive and NOT have GPA (or eGPA or MPA)? If so, what could cause this?
53:51 Is long-term use (years) of methotrexate considered safe for GPA (sinus) to keep it in remission?
54:55 What is the distinction between severe and non-severe GPA?
56:12 My nephrologist says I can stop or do 6 months or once a year. My rheumatologist says I should keep doing it every 6 months. How often should a person do rituximab after remission?
58:04 Do you ever see a delay between symptoms in patients and elevation of labs reflecting inflammation, and what is the typical timeframe between onset of symptoms and reflecting of inflammation in labs?

19 1

YouTube Video VVVlTHM5Vlp2SERIS3JjSGJmbnhZY1lnLjV1clpkRGFrc2lF

What You Need to Know about GPA 2025

vasculitisfoundation 21 hours ago

Watch this  informative and engaging webinar, “What You Need to Know About Inebilizumab (Uplizna®) for IgG4-RD 2025presented by Dr. Guy Katz, rheumatologist and clinician-investigator in the Division of Rheumatology, Allergy, & Immunology at the Massachusetts General Hospital in Boston, MA.UPLIZNA® is the first FDA-approved treatment for IgG4-related disease (IgG4-RD)—a rare, chronic, and often misdiagnosed condition that can affect multiple organs and systems of the body. Understanding this breakthrough therapy is vital for patients, caregivers, and healthcare professionals who want to stay informed about new treatment options that can make a real difference in patient care.0:003:59 What is IgG4-RD?9:00 What is Inebilizumab?9:37 How do antibodies work?10:12 How does inebilizumab work?14:45 B Cell deletion16:21 How is inebilizumab given?17:41 Does inebilizumab work?23:46 Inebilizumab vs. Rituximab27:44 Immunogenicity31:46 Glycoengineering32:16 Cost32:48 Side Effects34:15 Inebilizumab: Risk of Infection36:27 Inebilizumab: Vaccines40:38 How long to treat with inebilizumab?40:57 Inebilizumab: low antibody (immunoglobulin) levels42:45 Inebilizumab: low antibody (immunoglobulin) levels44:21 Summary44:59 Why should we as patients be interested and hopeful with this drug?View the PDF slide presentation: https://vasculitisfoundation.org/wp-content/uploads/2025/11/100525-VF-Inebilizumab.pdf Learn about VF resources at: www.vasculitisfoundation.org

Watch this informative and engaging webinar, “What You Need to Know About Inebilizumab (Uplizna®) for IgG4-RD 2025presented by Dr. Guy Katz, rheumatologist and clinician-investigator in the Division of Rheumatology, Allergy, & Immunology at the Massachusetts General Hospital in Boston, MA.

UPLIZNA® is the first FDA-approved treatment for IgG4-related disease (IgG4-RD)—a rare, chronic, and often misdiagnosed condition that can affect multiple organs and systems of the body. Understanding this breakthrough therapy is vital for patients, caregivers, and healthcare professionals who want to stay informed about new treatment options that can make a real difference in patient care.

0:00
3:59 What is IgG4-RD?
9:00 What is Inebilizumab?
9:37 How do antibodies work?
10:12 How does inebilizumab work?
14:45 B Cell deletion
16:21 How is inebilizumab given?
17:41 Does inebilizumab work?
23:46 Inebilizumab vs. Rituximab
27:44 Immunogenicity
31:46 Glycoengineering
32:16 Cost
32:48 Side Effects
34:15 Inebilizumab: Risk of Infection
36:27 Inebilizumab: Vaccines
40:38 How long to treat with inebilizumab?
40:57 Inebilizumab: low antibody (immunoglobulin) levels
42:45 Inebilizumab: low antibody (immunoglobulin) levels
44:21 Summary
44:59 Why should we as patients be interested and hopeful with this drug?

View the PDF slide presentation: https://vasculitisfoundation.org/wp-content/uploads/2025/11/100525-VF-Inebilizumab.pdf

Learn about VF resources at: www.vasculitisfoundation.org

5 0

YouTube Video VVVlTHM5Vlp2SERIS3JjSGJmbnhZY1lnLnhqX1NSVG5aRWJj

What You Need to Know About Inebilizumab-cdon (Uplizna®) for IgG4-RD 2025

vasculitisfoundation November 10, 2025 1:01 am

This webinar is designed specifically for patients with a new diagnosis of ANCA vasculitis, those concerned about future relapse, and/or those with previously treated relapse who are seeking to understand how to manage this challenging phase of their condition.  It's led by led by Dr. Mats Junek, MD, MSc, FRCPC, a rheumatologist and PhD candidate with expertise in vasculitis care and research at McMaster University in Ontario, Canada, as he addresses the critical topic of relapse in ANCA-associated vasculitis (AAV).0:007:02 What is remission with vasculitis?10:53 Symptoms with remission.14:10 No known triggers for relapse17:10 About maintenance therapy20:51 PEXIVAS risk of relapse estimation tool21:58 Measuring of risk of infection22:09 EGPA29:03 Future Research30:15 Take-home points32:09 How do treatment strategies differ between managing a relapse and managing the initial onset of vasculitis?35:30 Could the COVID or shingles vaccine be a possible trigger of a relapse?40:02 Is burning pain on the back of the thigh and aching, throbbing pain on the outer thigh, and sensitivity to touch a flare-up, and is each flare-up cumulative?42:43 For GPA patients on methotrexate, how long can one be off MTX for surgery without triggering a relapse?  Some doctors want patients to take methotrexate before and after surgery.44:47 If you normally get every 6 months Rituxan and have a flare-up, is it common to do 4 months a few times?51:21 Our immune systems weaken as we get into old age.  Is there a reduced risk of flares in seniors or those over 75?52:46 Some people remain ANCA positive while in remission.  Is there a difference in relapse rates between those who remain ANCA positive versus those who don’t?57:04 Communication between patient and doctor is critical, but we don’t want to overload an already stressed medical system. So when is it appropriate to check in with a doctor on a suspected flare? And what information is important to present?Visit the Vasculitis Foundation website to learn about all of our resources.  www.vasculitisfoundation.org

This webinar is designed specifically for patients with a new diagnosis of ANCA vasculitis, those concerned about future relapse, and/or those with previously treated relapse who are seeking to understand how to manage this challenging phase of their condition. It's led by led by Dr. Mats Junek, MD, MSc, FRCPC, a rheumatologist and PhD candidate with expertise in vasculitis care and research at McMaster University in Ontario, Canada, as he addresses the critical topic of relapse in ANCA-associated vasculitis (AAV).


0:00
7:02 What is remission with vasculitis?
10:53 Symptoms with remission.
14:10 No known triggers for relapse
17:10 About maintenance therapy
20:51 PEXIVAS risk of relapse estimation tool
21:58 Measuring of risk of infection
22:09 EGPA
29:03 Future Research
30:15 Take-home points
32:09 How do treatment strategies differ between managing a relapse and managing the initial onset of vasculitis?
35:30 Could the COVID or shingles vaccine be a possible trigger of a relapse?
40:02 Is burning pain on the back of the thigh and aching, throbbing pain on the outer thigh, and sensitivity to touch a flare-up, and is each flare-up cumulative?
42:43 For GPA patients on methotrexate, how long can one be off MTX for surgery without triggering a relapse? Some doctors want patients to take methotrexate before and after surgery.
44:47 If you normally get every 6 months Rituxan and have a flare-up, is it common to do 4 months a few times?
51:21 Our immune systems weaken as we get into old age. Is there a reduced risk of flares in seniors or those over 75?
52:46 Some people remain ANCA positive while in remission. Is there a difference in relapse rates between those who remain ANCA positive versus those who don’t?
57:04 Communication between patient and doctor is critical, but we don’t want to overload an already stressed medical system. So when is it appropriate to check in with a doctor on a suspected flare? And what information is important to present?

Visit the Vasculitis Foundation website to learn about all of our resources. www.vasculitisfoundation.org

30 4

YouTube Video VVVlTHM5Vlp2SERIS3JjSGJmbnhZY1lnLlp5NkRvSFNKVTJj

Relapse with ANCA vasculitis

vasculitisfoundation October 27, 2025 9:41 pm

Webinar Preview: What You Need to Know About Uplizna

vasculitisfoundation October 16, 2025 3:31 pm

Join us for an informative webinar designed for patients with vasculitis affecting the kidneys.  This webinar is ideal for patients, caregivers, and anyone seeking to better understand the impact of vasculitis on kidney health.   Presented by Dr. Suneel Udani.0:002:07 Survey of audience about impact of vasculitis on kidneys6:56 Understanding the kidney9:30 The Glomerulus10:33 Clinical manifestations12:15 An inflamed glomerulus18:29 Crescentic glomerulonephritis19:10 Clinical manifestations outside of the kidney20:26  Lab testing23:12 Treatment guide29:09 What should I expect during treatment?31:19 When should I feel better?32:27 Will I be cured?34:24 Maintenance of remission35:46 Treating kidney disease—general principles40:54 Q: Researchers are trying to resuscitate dead cells in diseases such as diabetes and spinal injury.  Are you aware of any research on recovering dead granules for kidneys?42:08 Q:  Are there clinical trials specifically focused on kidney involvement with vasculitis?44:28 Q:  Will a kidney damage occur more aggressively with a relapse if someone already has kidney damage/scarring?45:24 Q:  How do you know if the treatment is working between blood tests?  What is a reasonable time before each testing?48:21 Q:  Is it a cause for concern if I see a lot of bubbles and foam in my urine?49:30 Q:  Since high blood pressure is a sign of kidney disease, can taking blood pressure medicine "hide" kidney disease - especially a vasculitis flare?50:52 Q:  Frequent urination at night.  I understand the kidney normally concentrates urine at night but when damaged it may not do this.  Does this ever improve?52:35 Q:  I am an 82-yr old female diagnosed with MPO- ANCA in August 2025.  Are there any studies/ongoing research of "geriatric patients? “Or am I the lone wolf with this disease?53:46 Q:  While you are being treated (active disease) are the kidneys still sustaining damage?55:13 Q:  My doctor is watching my kidney numbers really close. At what point should I be concerned enough to see a nephrologist?

Join us for an informative webinar designed for patients with vasculitis affecting the kidneys. This webinar is ideal for patients, caregivers, and anyone seeking to better understand the impact of vasculitis on kidney health. Presented by Dr. Suneel Udani.

0:00
2:07 Survey of audience about impact of vasculitis on kidneys
6:56 Understanding the kidney
9:30 The Glomerulus
10:33 Clinical manifestations
12:15 An inflamed glomerulus
18:29 Crescentic glomerulonephritis
19:10 Clinical manifestations outside of the kidney
20:26 Lab testing
23:12 Treatment guide
29:09 What should I expect during treatment?
31:19 When should I feel better?
32:27 Will I be cured?
34:24 Maintenance of remission
35:46 Treating kidney disease—general principles
40:54 Q: Researchers are trying to resuscitate dead cells in diseases such as diabetes and spinal injury. Are you aware of any research on recovering dead granules for kidneys?
42:08 Q: Are there clinical trials specifically focused on kidney involvement with vasculitis?
44:28 Q: Will a kidney damage occur more aggressively with a relapse if someone already has kidney damage/scarring?
45:24 Q: How do you know if the treatment is working between blood tests? What is a reasonable time before each testing?
48:21 Q: Is it a cause for concern if I see a lot of bubbles and foam in my urine?
49:30 Q: Since high blood pressure is a sign of kidney disease, can taking blood pressure medicine "hide" kidney disease - especially a vasculitis flare?
50:52 Q: Frequent urination at night. I understand the kidney normally concentrates urine at night but when damaged it may not do this. Does this ever improve?
52:35 Q: I am an 82-yr old female diagnosed with MPO- ANCA in August 2025. Are there any studies/ongoing research of "geriatric patients? “Or am I the lone wolf with this disease?
53:46 Q: While you are being treated (active disease) are the kidneys still sustaining damage?
55:13 Q: My doctor is watching my kidney numbers really close. At what point should I be concerned enough to see a nephrologist?

37 5

YouTube Video VVVlTHM5Vlp2SERIS3JjSGJmbnhZY1lnLlA5by1QaENFbXJV

What You Need to Know About the Kidneys and Vasculitis October 2025

vasculitisfoundation October 14, 2025 1:47 pm

Watch this informative, insightful webinar exploring the impact of urticarial vasculitis (UV), a rare condition where small blood vessels in the skin become inflamed, leading to persistent, hive-like rashes that may burn or sting, often accompanied by systemic symptoms like joint pain or fatigue.This live webinar brings together two patients living with UV, sharing their personal experiences, alongside Dr. Galen Foulke, a renowned vasculitis specialist.0:00 2:43 Poll on impact of UV7:34 Roundtable question:  What are some of the biggest challenges you face with UV?7:48 Jessica’s response.9:14 Julie’s response.13:47 What management strategies have you tried and how have they impacted your core quality of life?18:02: What would your advice be to someone who has just been diagnosed with UV?26:53: Q:  I’ve read that UV can be part of a neoplastic syndrome for cancer. How much of a risk is this, and does it increase with autoantibodies also associated with neoplastic syndromes? Should we be having additional screenings or tests?29:23: Q:  The majority of my outbreaks are caused by medications.  Due to this, I am “allergic” to many medications.  Is this common to have most, if not all, outbreaks due to reactions to medications?32:55 Q:  Do you have advice on how to manage a work life or career when you are dealing with UV?35:50 Q:   My doctor diagnosed me with HUVS because I have lupus, so he said there is probably multiorgan involvement.  However, I question if that is true based on that.  Can that statement be made or do the complement levels have to be tested to diagnose HUVS after being diagnosed with UV?40:04 Q:  Can vaccinations like flu or COVID cause UV flare-ups?43:35 Q:  Do you have experience with prescribing Tacrolimus ointment?45:01 Q:  . Have you seen or do you believe GLP-1s can trigger and flare up? 2) Does microdosing of GLP-1s help decrease flare symptoms?47:22 Q:  Do you know of any research currently going on that could potentially help UV patients?48:42 Q:  Any last words of advice from Jessica and Julia?51:58 Learn about VF Resources, including Find-A-DoctorVisit the Vasculitis Foundation website to find more resources on Urticarial Vasculitis:  https://vasculitisfoundation.org/education/vasculitis-types/urticarial-vasculitis/

Watch this informative, insightful webinar exploring the impact of urticarial vasculitis (UV), a rare condition where small blood vessels in the skin become inflamed, leading to persistent, hive-like rashes that may burn or sting, often accompanied by systemic symptoms like joint pain or fatigue.

This live webinar brings together two patients living with UV, sharing their personal experiences, alongside Dr. Galen Foulke, a renowned vasculitis specialist.

0:00
2:43 Poll on impact of UV
7:34 Roundtable question: What are some of the biggest challenges you face with UV?
7:48 Jessica’s response.
9:14 Julie’s response.
13:47 What management strategies have you tried and how have they impacted your core quality of life?
18:02: What would your advice be to someone who has just been diagnosed with UV?
26:53: Q: I’ve read that UV can be part of a neoplastic syndrome for cancer. How much of a risk is this, and does it increase with autoantibodies also associated with neoplastic syndromes? Should we be having additional screenings or tests?
29:23: Q: The majority of my outbreaks are caused by medications. Due to this, I am “allergic” to many medications. Is this common to have most, if not all, outbreaks due to reactions to medications?
32:55 Q: Do you have advice on how to manage a work life or career when you are dealing with UV?
35:50 Q: My doctor diagnosed me with HUVS because I have lupus, so he said there is probably multiorgan involvement. However, I question if that is true based on that. Can that statement be made or do the complement levels have to be tested to diagnose HUVS after being diagnosed with UV?
40:04 Q: Can vaccinations like flu or COVID cause UV flare-ups?
43:35 Q: Do you have experience with prescribing Tacrolimus ointment?
45:01 Q: . Have you seen or do you believe GLP-1s can trigger and flare up? 2) Does microdosing of GLP-1s help decrease flare symptoms?
47:22 Q: Do you know of any research currently going on that could potentially help UV patients?
48:42 Q: Any last words of advice from Jessica and Julia?
51:58 Learn about VF Resources, including Find-A-Doctor

Visit the Vasculitis Foundation website to find more resources on Urticarial Vasculitis: https://vasculitisfoundation.org/education/vasculitis-types/urticarial-vasculitis/

19 6

YouTube Video VVVlTHM5Vlp2SERIS3JjSGJmbnhZY1lnLjF3R3BzSnprSTE0

Patient Roundtable: Living With Urticarial Vasculitis

vasculitisfoundation October 12, 2025 3:56 pm

Living with Urticarial Vasculitis?

vasculitisfoundation September 23, 2025 9:08 pm

0:002:42 Results of webinar survey of pulmonary involvement.5:24 Structure and vessels of the lungs.8:20 Our diagnostic tools.10:50 Asthma.17:16 Airway management:  Mucosal Inflammation.22:31 Lung nodules and cavities.25:09 Interstitial lung disease.27:59 Diffuse Alveolar Hemorrhage.29:55 Vascular stenoses & aneurysms.32:00 Potpourri33:18 Complications of treatment.35:09 Key points.36:00 Are pulmonary embolisms a potential result/symptom of GPA?37:28 If you have part of your lung removed, can it regenerate?38:30 In Dr. Fussner's career, how often has she seen or known a person needing a lung transplant due to vasculitis?39:22 If you have minimal lung scarring from bleeding in the lungs, what is the long-term effect of this scarring?40:44 Is a bronchoscopy painful?42:06 Has non-tuberculosis been a common diagnosis?42:49 Would you recommend a biopsy if imaging picks up a ground-glass nodule?44:48 How much of a factor does a prior history of smoking play in treating pulmonary issues in vasculitis?46:28 How long would vasculitis have to be untreated for some of these pulmonary complications, such as scarring? 47:39 Does Rituxan relieve inflammation in lung tissue and/or improve breathingView Dr. Fussner's webinar slide presentation here. https://shorturl.fm/NoYFiWatch this informative overview led by Dr. Lynn Fussner on vasculitis and its impact on the lungs (the pulmonary system). Vasculitis is a condition where your blood vessels become inflamed, which can affect various parts of the body, including the lungs. This can lead to breathing issues and other complications. Visit the Vasculitis Foundation to learn about our other resources at www.vasculitisfoundation.org.

0:00
2:42 Results of webinar survey of pulmonary involvement.
5:24 Structure and vessels of the lungs.
8:20 Our diagnostic tools.
10:50 Asthma.
17:16 Airway management: Mucosal Inflammation.
22:31 Lung nodules and cavities.
25:09 Interstitial lung disease.
27:59 Diffuse Alveolar Hemorrhage.
29:55 Vascular stenoses & aneurysms.
32:00 Potpourri
33:18 Complications of treatment.
35:09 Key points.
36:00 Are pulmonary embolisms a potential result/symptom of GPA?
37:28 If you have part of your lung removed, can it regenerate?
38:30 In Dr. Fussner's career, how often has she seen or known a person needing a lung transplant due to vasculitis?
39:22 If you have minimal lung scarring from bleeding in the lungs, what is the long-term effect of this scarring?
40:44 Is a bronchoscopy painful?
42:06 Has non-tuberculosis been a common diagnosis?
42:49 Would you recommend a biopsy if imaging picks up a ground-glass nodule?
44:48 How much of a factor does a prior history of smoking play in treating pulmonary issues in vasculitis?
46:28 How long would vasculitis have to be untreated for some of these pulmonary complications, such as scarring?
47:39 Does Rituxan relieve inflammation in lung tissue and/or improve breathing

View Dr. Fussner's webinar slide presentation here. https://shorturl.fm/NoYFi

Watch this informative overview led by Dr. Lynn Fussner on vasculitis and its impact on the lungs (the pulmonary system). Vasculitis is a condition where your blood vessels become inflamed, which can affect various parts of the body, including the lungs. This can lead to breathing issues and other complications.

Visit the Vasculitis Foundation to learn about our other resources at www.vasculitisfoundation.org.

23 0

YouTube Video VVVlTHM5Vlp2SERIS3JjSGJmbnhZY1lnLjVieXNkQzR6M3ZJ

Vasculitis and Pulmonary Issues 2025

vasculitisfoundation September 16, 2025 6:26 pm

Behcet's Disease Q&A September 2025

vasculitisfoundation September 16, 2025 1:12 pm

Understanding Clinical Studies_August 2025

vasculitisfoundation September 2, 2025 6:08 pm

Register for the Fatigue Roundtable Webinar

vasculitisfoundation August 22, 2025 2:11 pm

Register for the Behcet's Disease Q&A Webinar

vasculitisfoundation August 22, 2025 2:10 pm